Understanding primary immunodeficiency (PI)
Understanding PI
The more you understand about primary immunodeficiency (PI), the better you can live with the disease or support others in your life with PI. Learn more about PI, including the various diagnoses and treatment options.
Learn more about PI
Living with PI
Living with PI
Living with primary immunodeficiency (PI) can be challenging, but you’re not alone—many people with PI lead full and active lives. With the right support and resources, you can, too.
Learn more about living with PI
Get involved
Get involved
Be a hero for those with PI. Change lives by promoting primary immunodeficiency (PI) awareness and taking action in your community through advocacy, donating, volunteering, or fundraising.
Get involved today
Advancing research and clinical care
Advancing research and clinical care
Whether you’re a clinician, researcher, or an individual with primary immunodeficiency (PI), IDF has resources to help you advance the field. Get details on surveys, grants, and clinical trials.
View resource details

Chiesi Global Rare Diseases has acquired Unikeris Limited

November 24, 2020

Today, Chiesi Global Rare Diseases announced that it has acquired Unikeris Limited. In the primary immunodeficiency world, Unikeris Limited is a global marketer for Revcovi for the treatment of ADA-SCID. ADA-SCID is a type of PI that occurs in approximately one in 200,000 to 1,000,000 newborns worldwide.

Chiesi Group Acquires Unikeris Limited and Adds Revcovi® (elapegademase-lvlr) Injection to Product Portfolio

The addition of approved therapy for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) expands Chiesi commitment to addressing significant areas of unmet need in the treatment of rare diseases
Under terms of the agreement, Chiesi Group has acquired all rights to Revcovi, which will continue to be available to patients through Chiesi Global Rare Diseases, a business unit of Chiesi Group

To read the full press release, please visit: https://www.chiesiglobalrarediseases.com/